Its morbidity and mortality are the first in cardiovascular disease.[16] At present, the main surgical treatments are thrombolysis and PCI, including β-blocker, angiotensin-converting enzyme inhibitor (ACEI), angiotensin receptor antagonist, statins, antiplatelet drugs, receptor antagonists, and aldosterone antagonists. The gene discussed is ACE; the disease is cardiovascular disorder.